Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-017769
Filing Date
2016-04-07
Accepted
2016-04-07 17:00:25
Documents
1
Period of Report
2016-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3736
  Complete submission text file 0000899243-16-017769.txt   4957
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Adams Brian (Reporting) CIK: 0001636994 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 161560638